# Erasca (ERAS) — Analyst Forecast

ERAS · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/eras/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 8 | 2 | 0 | 10 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $20.00 | $21.00 | $22.00 | 4 |

Last price $14.87 (as of Oct 16, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Aug 14, 2026 | B of A Securities | Maintained | Neutral | $20.00 |
| Aug 13, 2026 | Guggenheim | Maintained | Buy | $21.00 |
| Aug 12, 2026 | HC Wainwright & Co. | Maintained | Buy | $22.00 |
| Jul 20, 2026 | Morgan Stanley | Maintained | Equal-Weight | $21.00 |
| Jul 14, 2026 | B of A Securities | Maintained | Neutral | $18.00 |
| Jun 4, 2026 | B of A Securities | Upgraded | Underperform → Neutral | $16.00 |
| May 12, 2026 | Mizuho | Maintained | Outperform | $26.00 |
| Apr 27, 2026 | Stifel | Maintained | Buy | $30.00 |
| Mar 18, 2026 | JP Morgan | Maintained | Overweight | $25.00 |
| Mar 16, 2026 | Guggenheim | Maintained | Buy | $20.00 |
| Mar 13, 2026 | HC Wainwright & Co. | Maintained | Buy | $20.00 |
| Mar 13, 2026 | Mizuho | Maintained | Outperform | $19.00 |
| Mar 13, 2026 | Piper Sandler | Maintained | Overweight | $18.00 |
| Mar 6, 2026 | Clear Street | Maintained | Buy | $20.00 |
| Jan 26, 2026 | HC Wainwright & Co. | Maintained | Buy | $15.00 |
| Jan 16, 2026 | Piper Sandler | Maintained | Overweight | $11.00 |
| Jan 13, 2026 | HC Wainwright & Co. | Maintained | Buy | $11.00 |
| Jan 7, 2026 | Piper Sandler | Initiated Coverage | Overweight | $5.00 |
| Dec 9, 2025 | Mizuho | Maintained | Outperform | $5.00 |
| Nov 14, 2025 | Guggenheim | Maintained | Buy | $5.00 |

## Frequently Asked Questions

### What is the price target for ERAS stock?

The average 12-month analyst price target for Erasca (ERAS) is $21.00, with a high estimate of $22.00 and a low of $20.00, across 4 analysts.

### Is ERAS a buy, sell, or hold?

Analysts covering Erasca currently average a Buy rating: 8 buy, 2 hold and 0 sell, from 10 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for ERAS?

The average price target of $21.00 implies 41.22% upside from the last price of $14.87.

### What is the latest analyst rating on ERAS?

On Aug 14, 2026, B of A Securities maintained Erasca at Neutral with a price target of $20.00.

## Similar Stocks

- [RVMD](https://www.lighthorse.io/tickers/rvmd) — Revolution Medicines, Inc. - Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).